Seminars in Nephrology
Volume 27, Issue 6 , Pages 627-636 , November 2007

Proteomics and Diabetic Nephropathy

  • Michael L. Merchant, PhD

      Affiliations

    • Kidney Disease Program, University of Louisville, Louisville, KY.
    • Clinical Proteomics Center, University of Louisville, Louisville, KY.
    • Corresponding Author InformationAddress reprint requests to Michael L. Merchant, Room 209, Donald Baxter Research Building, 570 S Preston St, Louisville, KY 40202.
    • ,
  • Jon B. Klein, MD, PhD

      Affiliations

    • Kidney Disease Program, University of Louisville, Louisville, KY.
    • Clinical Proteomics Center, University of Louisville, Louisville, KY.
    • Veterans Affairs Medical Center, Louisville, KY.

References 

  1. Susztak K, Bottinger EP. Diabetic nephropathy (a frontier for personalized medicine). J Am Soc Nephrol. 2006;17:361–367
  2. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep. 2006;6:479–483
  3. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat Rev Mol Cell Biol. 2006;7:867–873
  4. Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit. 2006;12:RA130–RA147
  5. Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 200;18:1353-61.
  6. Perkins BA, Krolewski AS. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep. 2005;5:455–463
  7. Perkins BA, Ficociello LH, Silva KH, et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348:2285–2293
  8. Kenyon GL, DeMarini DM, Fuchs E, et al. Defining the mandate of proteomics in the post-genomics era: workshop report. Mol Cell Proteomics. 2002;1:763–780
  9. Janech MG, Raymond JR, Arthur JM. Proteomics in renal research. Am J Physiol. 2007;292:F501–F512
  10. Fliser D, Novak J, Thongboonkerd V, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18:1057–1071
  11. Issaq HJ, Veenstra TD. The role of electrophoresis in disease biomarker discovery. Electrophoresis. 2007;28:1980–1988
  12. Veenstra TD. Global and targeted quantitative proteomics for biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;847:3–11
  13. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006;5:1760–1771
  14. Hoorn EJ, Pisitkun T, Zietse R. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton). 2005;10:283–290
  15. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol. 2004;15:1677–1689
  16. Wittke S, Fliser D, Haubitz M, et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr A. 2003;1013:173–181
  17. Fiedler GM, Baumann S, Leichtle A, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem. 2007;53:421–428
  18. Castagna A, Cecconi D, Sennels L, et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005;4:1917–1930
  19. Roelofsen H, Varez-Llamas G, Schepers M, et al. Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci 207;5:2.
  20. Wang L, Li F, Sun W, et al. Concanavalin A-captured glycoproteins in healthy human urine. Mol Cell Proteomics. 2006;5:560–562
  21. Sleat DE, Zheng H, Lobel P. The human urine mannose 6-phosphate glycoproteome. Biochim Biophys Acta. 2007;1774:368–372
  22. Thongboonkerd V, McLeish KR, Arthur JM, et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002;62:1461–1469
  23. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101:13368–13373
  24. Adachi J, Kumar C, Zhang Y, et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006;7:R80
  25. Zhang Y, Zhang Y, Adachi J, et al. MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res. 2007;35:D771–D779
  26. Varghese SA, Powell TB, Budisavljevic MN, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007;18:913–922
  27. Sharma K, Lee S, Han S, et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics. 2005;5:2648–2655
  28. Rao PV, Lu X, Standley M, et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care. 2007;30:629–637
  29. Otu HH, Can H, Spentzos D, et al. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care. 2007;30:638–643
  30. Meier M, Kaiser T, Herrmann A, et al. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complications. 2005;19:223–232
  31. Mischak H, Kaiser T, Walden M, et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond). 2004;107:485–495
  32. Rossing K, Mischak H, Parving HH, et al. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int. 2005;68:193–205
  33. Tilton RG, Haidacher SJ, Lejeune WS, et al. Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2007;7:1729–1742
  34. Diao WF, Chen WQ, Wu Y, et al. Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation. Proteomics. 2006;6:5837–5845
  35. Kim HJ, Cho EH, Yoo JH, et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res. 2007;6:735–743

PII: S0270-9295(07)00126-X

doi: 10.1016/j.semnephrol.2007.09.003

Seminars in Nephrology
Volume 27, Issue 6 , Pages 627-636 , November 2007

Article Tools

* Image Usage & Resolution